The exact role of GLUT5 in colon cancer is not yet fully elucidated, but other studies have shown that the inhibition of GLUT5 in CRC patients is linked to a decrease in the viability of the cancer cells. This evidence concerns the gene SLC2A5 and colorectal carcinoma.